Nephrotoxicity of mala fide melamine: modern era milk scandal

Rakesh Lattupalli1, Jerry Yee, Anuradha Kolluru

  • 1Division of Nephrology, Henry Ford Hospital, Detroit, MI, USA. RLATTUP1@hfhs.org

Insights

Melamine, found in adulterated milk, has caused acute kidney failure in humans. Further research is needed to understand how melamine causes kidney disease and its risks.

Area of Science:

  • Toxicology
  • Nephrology
  • Food Safety

Background:

  • Melamine's nephrotoxicity was initially identified in pets, leading to recalls.
  • Previously considered a low human health risk, melamine is now linked to acute renal failure.

Purpose of the Study:

  • To review the emerging evidence of melamine-induced nephrotoxicity in humans.
  • To highlight the public health concerns associated with melamine adulteration in food products.

Main Methods:

  • Literature review of reported cases and toxicological data.
  • Analysis of the mechanism of melamine in causing kidney damage.

Main Results:

  • Melamine adulteration in milk has led to widespread acute renal failure outbreaks.
  • The high nitrogen content of melamine allows for fraudulent protein level inflation in diluted milk.

Conclusions:

  • The exact pathophysiology of melamine-induced kidney disease in humans remains unclear.
  • Avoiding melamine exposure is recommended until a comprehensive scientific understanding is achieved.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...